Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALGR
1601
DELISTED
Allegro Merger Corp
ALGR
| $4.88M | 0.01% |
500,000
| – | – |
|
1602
WPP
WPP
$5.58B
| $4.86M | 0.01% |
88,678
+74,378
| +520% | +$4.43M |
|
|
MIME
1603
DELISTED
Mimecast Limited
MIME
| $4.82M | 0.01% |
143,220
-69,652
| -33% | -$2.43M |
|
|
SAGE
1604
PUT
DELISTED
Sage Therapeutics
SAGE
| $4.81M | 0.01% |
+50,200
| New | +$5.75M |
|
1605
PUT
Whirlpool
WHR
$2.62B
| $4.81M | 0.01% |
+45,000
| New | +$5.1M |
|
|
AXON
1606
Axon Enterprise
AXON
$49.4B
| $4.81M | 0.01% |
+109,874
| New | +$5.7M |
|
|
GOOD
1607
Gladstone Commercial Corp
GOOD
$630M
| $4.8M | 0.01% |
268,085
+53,532
| +25% | +$1M |
|
1608
Copa Holdings
CPA
$5.99B
| $4.8M | 0.01% |
+60,997
| New | +$4.78M |
|
1609
Weibo
WB
$1.73B
| $4.79M | 0.01% |
82,020
+18,151
| +28% | +$1.1M |
|
1610
CALL
Intuitive Surgical
ISRG
$131B
| $4.79M | 0.01% |
30,000
-9,000
| -23% | -$1.53M |
|
1611
Towne Bank
TOWN
$3.47B
| $4.77M | 0.01% |
199,079
-103,869
| -34% | -$2.85M |
|
|
MCRN
1612
DELISTED
Milacron Holdings Corp.
MCRN
| $4.74M | 0.01% |
398,614
+372,070
| +1,402% | +$5.59M |
|
1613
UroGen Pharma
URGN
$2.25B
| $4.73M | 0.01% |
109,892
-123,461
| -53% | -$5.55M |
|
|
CORE
1614
DELISTED
Core Mark Holding Co., Inc.
CORE
| $4.72M | 0.01% |
203,031
-395,685
| -66% | -$12M |
|
1615
Eastman Chemical
EMN
$8.34B
| $4.71M | 0.01% |
64,405
-295,270
| -82% | -$23.5M |
|
1616
Yext
YEXT
$652M
| $4.69M | 0.01% |
316,051
-128,607
| -29% | -$2.27M |
|
|
NXRT
1617
NexPoint Residential Trust
NXRT
$619M
| $4.67M | 0.01% |
133,273
-458,081
| -77% | -$15.9M |
|
1618
Century Aluminum
CENX
$4.35B
| $4.67M | 0.01% |
+638,553
| New | +$5.79M |
|
1619
CALL
Zimmer Biomet
ZBH
$19.3B
| $4.67M | 0.01% |
46,350
-108,150
| -70% | -$12.2M |
|
|
CONN
1620
DELISTED
Conn's Inc.
CONN
| $4.67M | 0.01% |
247,462
-399,879
| -62% | -$10.8M |
|
1621
PUT
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.68B
| $4.66M | 0.01% |
+46,267
| New | +$4.83M |
|
1622
Autohome
ATHM
$2.55B
| $4.65M | 0.01% |
59,486
+35,106
| +144% | +$2.65M |
|
1623
Protagonist Therapeutics
PTGX
$9.8B
| $4.64M | 0.01% |
690,151
-343,647
| -33% | -$2.73M |
|
1624
Perrigo
PRGO
$2.05B
| $4.63M | 0.01% |
119,486
+110,379
| +1,212% | +$7.01M |
|
|
AGN
1625
DELISTED
Allergan plc
AGN
| $4.62M | 0.01% |
34,591
-247,090
| -88% | -$40.5M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.